Europe Molecular Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Molecular Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Molecular Diagnostics Market Regional Analysis

6.2 Europe Molecular Diagnostics Market Revenue 2020-2030 (US$ Million)

6.3 Europe Molecular Diagnostics Market Forecast Analysis

7. Europe Molecular Diagnostics Market Analysis – by Disease Area

7.1 Oncology

7.1.1 Overview
7.1.2 Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Infectious Disease

7.2.1 Overview
7.2.2 Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Genetic Testing

7.3.1 Overview
7.3.2 Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Cardiac Diseases

7.4.1 Overview
7.4.2 Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.5 Immune System Disorders

7.5.1 Overview
7.5.2 Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Molecular Diagnostics Market Analysis – by Technology

8.1 Polymerase Chain Reaction

8.1.1 Overview
8.1.2 Polymerase Chain Reaction: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Isothermal Nucleic Acid Amplification Technology

8.2.1 Overview
8.2.2 Isothermal Nucleic Acid Amplification Technology: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 DNA Sequencing & Next-Generation Sequencing

8.3.1 Overview
8.3.2 DNA Sequencing & Next-Generation Sequencing: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.4 DNA Microarrays

8.4.1 Overview
8.4.2 DNA Microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.5 In-Situ Hybridization

8.5.1 Overview
8.5.2 In-Situ Hybridization: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Molecular Diagnostics Market Analysis – by Product and Services

9.1 Assays & Kits

9.1.1 Overview
9.1.2 Assays & Kits: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Instruments

9.2.1 Overview
9.2.2 Instruments: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Services & Software

9.3.1 Overview
9.3.2 Services & Software: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Molecular Diagnostics Market Analysis – by End User

10.1 Hospitals & Clinics

10.1.1 Overview
10.1.2 Hospitals & Clinics: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Diagnostic Laboratories

10.2.1 Overview
10.2.2 Diagnostic Laboratories: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.3 Research & Academic Institutes

10.3.1 Overview
10.3.2 Research & Academic Institutes: Europe Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Europe Molecular Diagnostics Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Molecular Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Europe Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 UK: Europe Molecular Diagnostics Market Breakdown, by Disease Area
11.2.1.1.2 UK: Europe Molecular Diagnostics Market Breakdown, by Technology
11.2.1.1.3 UK: Europe Molecular Diagnostics Market Breakdown, by Product and Services
11.2.1.1.4 UK: Europe Molecular Diagnostics Market Breakdown, by End User

11.2.1.2 Germany: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Germany: Europe Molecular Diagnostics Market Breakdown, by Disease Area
11.2.1.2.2 Germany: Europe Molecular Diagnostics Market Breakdown, by Technology
11.2.1.2.3 Germany: Europe Molecular Diagnostics Market Breakdown, by Product and Services
11.2.1.2.4 Germany: Europe Molecular Diagnostics Market Breakdown, by End User

11.2.1.3 France: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 France: Europe Molecular Diagnostics Market Breakdown, by Disease Area
11.2.1.3.2 France: Europe Molecular Diagnostics Market Breakdown, by Technology
11.2.1.3.3 France: Europe Molecular Diagnostics Market Breakdown, by Product and Services
11.2.1.3.4 France: Europe Molecular Diagnostics Market Breakdown, by End User

11.2.1.4 Russia: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Russia: Europe Molecular Diagnostics Market Breakdown, by Disease Area
11.2.1.4.2 Russia: Europe Molecular Diagnostics Market Breakdown, by Technology
11.2.1.4.3 Russia: Europe Molecular Diagnostics Market Breakdown, by Product and Services
11.2.1.4.4 Russia: Europe Molecular Diagnostics Market Breakdown, by End User

11.2.1.5 Italy: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Italy: Europe Molecular Diagnostics Market Breakdown, by Disease Area
11.2.1.5.2 Italy: Europe Molecular Diagnostics Market Breakdown, by Technology
11.2.1.5.3 Italy: Europe Molecular Diagnostics Market Breakdown, by Product and Services
11.2.1.5.4 Italy: Europe Molecular Diagnostics Market Breakdown, by End User

11.2.1.6 Rest of Europe: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Molecular Diagnostics Market Breakdown, by Disease Area
11.2.1.6.2 Rest of Europe: Europe Molecular Diagnostics Market Breakdown, by Technology
11.2.1.6.3 Rest of Europe: Europe Molecular Diagnostics Market Breakdown, by Product and Services
11.2.1.6.4 Rest of Europe: Europe Molecular Diagnostics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Agilent Technologies Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 bioMerieux SA

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Danaher

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 F. Hoffmann-La Roche Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Illumina Inc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Novartis AG

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Qiagen NV

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Siemens Healthineers AG

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Thermo Fisher Scientific Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Molecular Diagnostics Market